Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 826 participants.
Also called NCT04452149
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 826 participants
- Registry
-
NCT04452149
-
- Other papers using this trial's data
- Arrhythmia Burden and Clinical Responses Under Continuous Monitoring in Heart Failure: Observations From the ALLEVIATE-HF Trial
- Risk-Based Nurse-Managed Personalized Heart Failure Interventions: The ALLEVIATE-HF Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT04452149. Randomized; quadruple masking; primary purpose treatment. Start 2020-09-03 (actual); primary completion 2025-06-02 (actual). Results posted on 2026-08-26.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure
- Acronym
- ALLEVIATE-HF
- Condition
- Heart Failure NYHA Class II
- Condition
- Heart Failure NYHA Class III
- Intervention (Device)
- Reveal LINQ™ Insertable Cardiac Monitor with investigational ALLEVIATE-HF RAMware download
- Intervention (Other)
- Medication intervention
- Intervention (Other)
- Not Randomized to Device or Medication Intervention
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart Failure
Record details
- Record id
cardio:ct-nct04452149- Content hash
3d4e50bf5ea4fb18c519230a74c2e06ddb37926421f3f56e8c689a9fc134cb8b